Additionally, small clusters represented obese patients with gastrointestinal disorders and cancers or liver disease (including fatty liver, another candidate of the metabolic syndrome) or patients with reproductive or urogenital problems in our analysis, all well-known comorbidities based on obesity-related hormonal imbalance, inflammation and insulin resistance [50]. This evidence concerns the gene INS and cancer.